Reports on the expression and function of IGFBP-5 in various cancers have been contradictory5, 8, 13, 32, and in this study we found that IGFBP5 was significantly downregulated in ovarian cancer patient tissues and ovarian cancer cell lines relative to normal controls. Here, IGFBP5 is linked to ovarian carcinoma.